A phase II trial of azacitidine with ipilimumab, nivolumab, or ipilimumab and nivolumab in previously untreated myelodysplastic syndrome

Ian M. Bouligny; Guillermo MontalbanBravo; Koji Sasaki; Naval Daver; Elias Jabbour; Yesid Alvarado; Courtney D. DiNardo; Farhad Ravandi; Gautam Borthakur; Prithviraj Bose; Naveen Pemmaraju; Steven Kornblau; Tapan Kadia; Lucia Masarova; Koichi Takahashi; Michael Andreeff; Alexandre Bazinet; Hui Yang; Rashmi KanagalShamanna; Chitra Hosing; Sherry Pierce; Meghan Meyer; Xuelin Huang; Guillermo GarciaManero

doi:10.3324/haematol.2024.286559

A phase II trial of azacitidine with ipilimumab, nivolumab, or ipilimumab and nivolumab in previously untreated myelodysplastic syndrome

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	1628-1633
Number of pages	6
Journal	Haematologica
Volume	110
Issue number	7
DOIs	https://doi.org/10.3324/haematol.2024.286559
State	Published - Jul 2025

ASJC Scopus subject areas

Hematology

Access to Document

10.3324/haematol.2024.286559

Cite this

@article{f17b767ab99b45b69064487210f3c2fb,

title = "A phase II trial of azacitidine with ipilimumab, nivolumab, or ipilimumab and nivolumab in previously untreated myelodysplastic syndrome",

author = "Bouligny, \{Ian M.\} and Guillermo MontalbanBravo and Koji Sasaki and Naval Daver and Elias Jabbour and Yesid Alvarado and DiNardo, \{Courtney D.\} and Farhad Ravandi and Gautam Borthakur and Prithviraj Bose and Naveen Pemmaraju and Steven Kornblau and Tapan Kadia and Lucia Masarova and Koichi Takahashi and Michael Andreeff and Alexandre Bazinet and Hui Yang and Rashmi KanagalShamanna and Chitra Hosing and Sherry Pierce and Meghan Meyer and Xuelin Huang and Guillermo GarciaManero",

year = "2025",

month = jul,

doi = "10.3324/haematol.2024.286559",

language = "English (US)",

volume = "110",

pages = "1628--1633",

journal = "Haematologica",

issn = "0390-6078",

publisher = "Ferrata Storti Foundation",

number = "7",

}

TY - JOUR

T1 - A phase II trial of azacitidine with ipilimumab, nivolumab, or ipilimumab and nivolumab in previously untreated myelodysplastic syndrome

AU - Bouligny, Ian M.

AU - MontalbanBravo, Guillermo

AU - Sasaki, Koji

AU - Daver, Naval

AU - Jabbour, Elias

AU - Alvarado, Yesid

AU - DiNardo, Courtney D.

AU - Ravandi, Farhad

AU - Borthakur, Gautam

AU - Bose, Prithviraj

AU - Pemmaraju, Naveen

AU - Kornblau, Steven

AU - Kadia, Tapan

AU - Masarova, Lucia

AU - Takahashi, Koichi

AU - Andreeff, Michael

AU - Bazinet, Alexandre

AU - Yang, Hui

AU - KanagalShamanna, Rashmi

AU - Hosing, Chitra

AU - Pierce, Sherry

AU - Meyer, Meghan

AU - Huang, Xuelin

AU - GarciaManero, Guillermo

PY - 2025/7

Y1 - 2025/7

UR - https://www.scopus.com/pages/publications/105009552032

UR - https://www.scopus.com/inward/citedby.url?scp=105009552032&partnerID=8YFLogxK

U2 - 10.3324/haematol.2024.286559

DO - 10.3324/haematol.2024.286559

M3 - Letter

C2 - 39973365

AN - SCOPUS:105009552032

SN - 0390-6078

VL - 110

SP - 1628

EP - 1633

JO - Haematologica

JF - Haematologica

IS - 7

ER -

A phase II trial of azacitidine with ipilimumab, nivolumab, or ipilimumab and nivolumab in previously untreated myelodysplastic syndrome

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this